Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Non-cash Items Other Working Capital Changes Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Income Statement

Others

Ratios

Immunome (IMNM) Change in Intangibles (2024)

Immunome (IMNM) has disclosed Change in Intangibles for 1 consecutive years, with $15.0 million as the latest value for Q1 2024.